Ablation endocavitaire des tachycardies supraventriculaires chez les adultes porteurs d'une cardiopathie congénitale : étude de cohorte rétrospective au CHU de Nantes |
|
Analysis of Heart Rhythm Disorders using Induced Pluripotent Stem Cells. |
|
Approche génétique des pathologies cardiaques rythmiques et valvulaires |
|
Caractéristiques cliniques et pronostiques d'une cohorte de 124 patients avec laminopathie génotypés au centre de référence des maladies cardiaques rares ou héréditaires de l'Ouest |
|
Comparaison des performances diagnostiques du mental stress test, de l'épreuve d'effort et du test à l'adrénaline chez les patients porteurs d'un syndrome du QT long avec un QTc < 480 ms |
|
A connexin40 mutation associated with a malignant variant of progressive familial heart block type I |
|
Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients |
|
Cosegregation of the Marfan syndrome and the long QT syndrome in the same family leads to a severe cardiac phenotype |
|
Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation |
|
Dépistage familial après une mort subite inexpliquée avant 45 ans : l'expérience du CHU de Nantes |
|
Devenir des blocs atrioventriculaires isolés non immuns diagnostiqués in utero ou dans l'enfance : une étude rétrospective |
|
Devenir rythmique des patients implantés d'un Défibrillateur Automatique Implantable en prévention primaire dans le cadre d'une cardiopathie sévère : expérience nantaise |
|
Differential calcium sensitivity in NaV 1.5 mixed syndrome mutants. |
|
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) |
|
Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease |
|
Dysfunction of the Voltage-Gated K+ Channel β2 Subunit in a Familial Case of Brugada Syndrome |
|
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls |
|
Étude de la réponse au Nadolol et aide à la titration par l'épreuve d'effort dans le syndrome du QT long congénital |
|
Étude de maladies du rythme cardiaque à l'aide de cellules souches pluripotentes induites |
|
Étude GENECHOC : identification des facteurs cliniques et génétiques modulant le risque rythmique chez les patients à fonction ventriculaire gauche altérée |
|
Étude phénotypique d'un nouveau variant sur le gène de l'alpha actinine 2, responsable de mort subite |
|
Étude QUIDAM : évaluation de l'intérêt d'un traitement par hydroquinidine pour la prise en charge des patients atteints d'un syndrome de Brugada à risque rythmique élevé et implantés d'un défibrillateur |
|
Évaluation du pronostic et de la prise en charge du syndrome du QT long congénital confirmé génétiquement chez l'enfant non-propositus |
|
Évaluation du pronostic rythmique des syndromes coronaires aigües à coronaires saines et fraction d'éjection préservée |
|
Évaluation rétrospective de la valeur diagnostique des différents examens réalisés dans le bilan d'une suspicion de Dysplasie Arythmogène du Ventricule Droit |
|
Facteurs modificateurs du rétrécissement aortique évaluation du rôle de l'hérédité |
|
Familial Catecholamine-Induced QT Prolongation in Unexplained Sudden Cardiac Death. |
|
Genetic and molecular basis of atrio-ventricular block diagnosed in utero or early childhood. |
|
Genetic approach of cardiac arrhythmias and valvulopathies. |
|
Genetic association analyses highlight biological pathways underlying mitral valve prolapse |
|
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization |
|
Heart rate variability and repolarization characteristics in symptomatic and asymptomatic Brugada syndrome. |
|
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome |
|
Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1. |
|
Incomplete Timothy syndrome secondary to a mosaic mutation of the CACNA1C gene diagnosed using next-generation sequencing |
|
Inherited progressive cardiac conduction disorders |
|
Insufficiency of electrocardiogram alone in predicting infrahisian abnormalities in patients with type 1 myotonic dystrophy |
|
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing |
|
Long-term follow-up of patients with short QT syndrome |
|
MEPPC : état de la question 10 ans après sa description, mise en route du registre européen = EPPC : the state of the question 10 years after its description, launch of the european register |
|
MOG1: a new susceptibility gene for Brugada syndrome. |
|
Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study. |
|
Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. |
|
New Family With Catecholaminergic Polymorphic Ventricular Tachycardia Linked to the Triadin Gene |
|
New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study |
|
Nombre de dérivations diagnostiques dans le syndrome de Brugada |
|
Orientation rythmologique en médecine générale |
|
Parental electrocardiographic screening identifies a high degree of inheritance for congenital and childhood nonimmune isolated atrioventricular block |
|
Physiopathologie moléculaire du syndrome de Brugada au cours du développement cardiaque |
|
Plakophilin and gene study in familial Brugada sundrome |
|
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope |
|
Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator—the EVADEF study |
|
Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Results of a systematic screening |
|
Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome |
|
Prognostic significance of fever-induced Brugada syndrome. |
|
Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis |
|
Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation. |
|
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. |
|
Quinidine therapy in children affected by Brugada syndrome: are we far from a safe alternative? |
|
Reply to the Editor-Brugada syndrome is not an ECG. |
|
Reply to the Editor--PQ-segment depression in short QT syndrome patients: a novel marker for diagnosing short QT syndrome? |
|
Response to the Letter by Kattygnarath et al |
|
Risk of ventricular arrhythmia in patients with myocardial infarction and non-obstructive coronary arteries and normal ejection fraction |
|
Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome. |
|
Safety, feasibility, and outcome results of cardiac resynchronization with triple-site ventricular stimulation compared to conventional cardiac resynchronization. |
|
SCN5A Mutation Type and a Genetic Risk Score Associate Variably with Brugada Syndrome Phenotype in SCN5A Families |
|
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome |
|
Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. |
|
Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity. |
|
Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. |
|
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans |
|
La stimulation épicardique en pédiatrie : plus de 10 ans d'expérience au CHU de Nantes |
|
Sudden cardiac arrest associated with early repolarization |
|
Suivi à long terme de 190 patients après Tilt-test |
|
Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I |
|
Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS) |
|
Troubles de conduction isolés progressifs héréditaires : étude clinique et moléculaire de familles |
|
Les troubles de la conduction dégénératifs : "Du malade au gène" |
|
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies |
|
Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]). |
|
Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation |
|
Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model |
|
Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes |
|
Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome. |
|